Abstract
Objective: To report a rare case of hemorrhage stroke caused by a lenticulostriate aneurysmal rupture missed initially by both multidetector cerebral CT angiography and digital subtraction angiography. Background Intracerebral hemorrhage is the deadliest form of stroke. Cerebral angiography is not routinely performed in typical deep intracranial hemorrhage which is often associated with hypertension. In as many as a third of cases of deep ICH, however, there is a treatable underlying structural lesion. We report a case of lenticulostriate artery aneurysmal rupture-a rare subtype of vascular abnormality-which led to a diagnostically challenging but ultimately treatable case of ICH. Design/Methods: Case report. Results: A 41 year-old female presented with headache, diaphoresis, agitation, and left-sided visual-spatial and limb asomatognosia, and hemiparesis. Cerebral CT scan showed an acute intracerebral hemorrhage approximately 28cc in volume centered near the right superior temporal lobe and centrum semiovale. Multidetector CT angiography performed did not reveal definitive evidence of any vascular abnormality. Cerebral catheter-based angiography was also initially negative. On hospital day 4, the patient had increased headache and somnolence with expansion of her intracerebral hemorrhage. Repeat angiogram demonstrated a 3mm distal lenticulostriate aneurysm which was then surgically clipped. The patient underwent extensive physical rehabilitation and was left with residual left arm greater than leg weakness with otherwise good neurological recovery. Repeat cerebral angiogram 3 months later showed resolution of the aneurysm. Conclusions: This is a rare case of intracerebral hemorrhage caused by rupture of a distal lenticulostriate artery aneurysm. After extensive neuroimaging, an underlying aneurysm was discovered. Patients without history of hypertension, who are under the age of 45, and who have atypical hematoma patterns or expansion of ICH after presentation should undergo neuroimaging for underlying structural lesion. Disclosure: Dr. Cai has nothing to disclose. Dr. Han has received personal compensation for activities with Harvard/MIT Health Sciences and Technology-Beth Israel Deaconess Medical Center in collaboration with Pfizer Inc and Merck & Co. Dr. Chou has nothing to disclose.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.